KPP Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
KPP Advisory Services's VRTX Position: Q2 2026 in Review
KPP Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 7.1% in Q2 2026, selling an estimated $18.6K and leaving 549 shares worth $273K. The position accounts for 0.03% of the portfolio, ranked #317.
KPP Advisory Services first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $440K in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- KPP Advisory Services held 549 shares of Vertex Pharmaceuticals worth $273K as of Q2 2026.
- KPP Advisory Services sold 42 Vertex Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
- Vertex Pharmaceuticals made up 0.03% of KPP Advisory Services's portfolio in Q2 2026, its #317 holding.
- KPP Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
- KPP Advisory Services's Vertex Pharmaceuticals position peaked at $440K in Q1 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on KPP Advisory Services's 13F filing for Q2 2026, filed 24 Jul 2026.